Literature DB >> 18677722

Pecuniary compensation increases participation in screening for colorectal cancer.

Eline Aas1.   

Abstract

The participation rate in medical screening programmes is typically below 100%, which means that not all potential health benefits are fully exploited. In this paper, the prospect of pecuniary compensation is tested as a method of increasing the participation rate. We propose a model explaining the individual's probability of participating in screening for colorectal cancer when he is offered pecuniary compensation, given that he did not participate when first invited. The participant's decision is based on both known and uncertain factors. The estimation is conducted in two steps, where a binary probit model is used in each. We find that pecuniary compensation increases the probability of participation, and that an individual's participation probability systematically varies with variables such as travel expenses, income, age, education level, expected benefit from the screening, use of health-care services, genetic predisposition and subjective health status. Using the results from the estimation, we predict changes in the participation rate for different levels of compensation and estimate the cost per additional individual screened. The cost per additional individual screened is 808, including 25 in compensation; this cost increases with the level of compensation.

Entities:  

Mesh:

Year:  2009        PMID: 18677722     DOI: 10.1002/hec.1371

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  3 in total

1.  Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid-enrolled colon cancer patients?

Authors:  Alica S Sparling; Eunyoung Song; Heidi D Klepin; Kristie L Foley
Journal:  J Gastrointest Oncol       Date:  2016-06

2.  Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.

Authors:  E A Burger; J D Ortendahl; S Sy; I S Kristiansen; J J Kim
Journal:  Br J Cancer       Date:  2012-03-22       Impact factor: 7.640

3.  Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing.

Authors:  Edoardo Botteri; Geir Hoff; Kristin R Randel; Øyvind Holme; Thomas de Lange; Tomm Bernklev; Eline Aas; Mona Berthelsen; Erik Natvig; Benedicte Kirkøen; Markus D Knudsen; Ane S Kvaerner; Anna L Schult; Giske Ursin; Anita Jørgensen; Paula Berstad
Journal:  Int J Cancer       Date:  2022-04-22       Impact factor: 7.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.